SUNNYVALE, Calif.--(BUSINESS WIRE)--Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced that it will stream the first live transmission case demonstration of its breakthrough DESolve® Cx Novolimus Eluting Bioresorbable Coronary Scaffold System at the 27th annual Transcatheter Cardiovascular Technologies (TCT) Conference in San Francisco, California, on Monday, October 12. The Elixir Satellite Symposium is scheduled for Wednesday, October 14.
Help employers find you! Check out all the jobs and post your resume.
